The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000212.3(ITGB3):c.1641C>A (p.Cys547Ter)

CA400030168

977131 (ClinVar)

Gene: ITGB3
Condition: Glanzmann thrombasthenia
Inheritance Mode: Autosomal recessive inheritance
UUID: 08d055ef-9deb-4c6a-bd3b-7d6bc0b854f4

HGVS expressions

NM_000212.3:c.1641C>A
NM_000212.3(ITGB3):c.1641C>A (p.Cys547Ter)
NC_000017.11:g.47292519C>A
CM000679.2:g.47292519C>A
NC_000017.10:g.45369885C>A
CM000679.1:g.45369885C>A
NC_000017.9:g.42724884C>A
NG_008332.2:g.43678C>A
ENST00000559488.7:c.1641C>A
ENST00000559488.5:c.1641C>A
ENST00000560629.1:n.1606C>A
NM_000212.2:c.1641C>A

Pathogenic

Met criteria codes 4
PP4_Strong PM3_Supporting PM2_Supporting PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The NM_000212.3(ITGB3):c.1641C>A (p.Cys547Ter) variant in exon 10/15 is a nonsense variant predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). It has been reported homozygous (PM3_supporting) in at least one GT proband (P18 in PMID: 34275420) who displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, αIIbβ3 surface expression was absent, as measured by flow cytometry (PP4_strong). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, based on the available evidence at this time, the variant is classified as pathogenic for GT. GT-specific criteria applied: PVS1, PM2_Supporting, PM3_supporting, PP4_strong.
Met criteria codes
PP4_Strong
At least one patient (P18 in PMID: 34275420) with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, αIIbβ3 surface expression was reduced to <5%, as measured by flow cytometry. ITGA2B and ITGB3 were sequenced across all exons and intron/exon boundaries. (PP4_strong)
PM3_Supporting
P18 is homozygous for this variant (PMID: 34275420; PM3_supporting)
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PVS1
The c.1641C>A (p.Cys547Ter) variant in exon 10/15 is a nonsense variant predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
Approved on: 2022-09-20
Published on: 2022-12-07
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.